Re: Why now?
in response to
by
posted on
Jan 12, 2021 09:22AM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
CCD, have you not been keeping up with the ZHCLF- Zenith Capital Corp OTCMarket quotes for the stock. That is what TD is following to adjust the share price. I'm waiting for it to drop a lot more so I can jump on board.
https://www.otcmarkets.com/stock/ZHCLF/profile
Koo